(Q41594629)

4 October 2017

1 reference

title

Expression of ras proto-oncogenes: regulation and implications in the development of human tumors (English)

1 reference

4 October 2017

Zachos G

1

1 reference

PubMed ID

9298325

4 October 2017

Spandidos DA

series ordinal

2

1 reference

4 October 2017

1 July 1997

1 reference

Critical Reviews in Oncology Hematology

4 October 2017

1 reference

4 October 2017

26

1 reference

4 October 2017

2

1 reference

4 October 2017

65-75

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

4 October 2017

1 reference

7 January 2021

Function and regulation of ras.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Expression of the H-ras proto-oncogene is controlled by alternative splicing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Transcriptional enhancer activity in the variable tandem repeat DNA sequence downstream of the human Ha-ras 1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

A repetitive sequence element 3' of the human c-Ha-ras1 gene has enhancer activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

The p21 ras C-terminus is required for transformation and membrane association

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

ras gene Amplification and malignant transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Malignant transformation of early passage rodent cells by a single mutated human oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Promoter region of the human Harvey ras proto-oncogene: similarity to the EGF receptor proto-oncogene promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Phorbol ester-responsive H-ras1 gene promoter contains multiple TPA-inducible/AP-1-binding consensus sequence elements.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Binding of the Sp1 transcription factor by the human Harvey ras1 proto-oncogene promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Identification of the principal promoter sequence of the c-H-ras transforming oncogene: deletion analysis of the 5'-flanking region by focus formation assay

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

c-Ha-ras gene bidirectional promoter expressed in vitro: location and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Deletion analysis of the c-Ha-ras oncogene promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Transcriptional control of the human Harvey ras proto-oncogene: role of multiple elements in the promoter region

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Regulatory elements mediating transcription of the human Ha-ras gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Differential potency and trans-activation of normal and mutant T24 human H-ras1 gene promoters

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Members of therel/NF-χB family of transcriptional regulatory proteins bind theHRAS1minisatellite DNA sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Comparative analysis of the methylation status of the 5' flanking region of Ha-ras in B6C3F1, C3H/He and C57BL/6 mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

In vitro DNA cytosine methylation of cis-regulatory elements modulates c-Ha-ras promoter activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Expression of Kirsten-ras p21 in gastric cancer correlates with tumor progression and is prognostic

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Clinical significance of ras p21 overexpression for patients with an advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

c-erbB-2 andras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Allele loss and point mutation in codons 12 and 61 of the c-Ha-ras oncogene in carcinogen-transformed human breast epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Establishment of hormone-dependent and hormone-independent carcinoma cell lines with different metastatic potentials from spontaneous mammary tumors in aged Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

ras oncogene is expressed in adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Mutations and expression of the ras family genes in leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Steroid hormone-induced expression of oncogene encoded nuclear proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Glucocorticoid and estrogen receptors have elevated activity in human endometrial and ovarian tumors as compared to the adjacent normal tissues and recognize sequence elements of the H-ras proto-oncogene.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Persistent estrogen responsiveness of ras oncogene-transformed mouse mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900013-9

7 January 2021

10.1016/S1040-8428(97)00013-9

Identifiers

DOI

1 reference

4 October 2017

1 reference

PubMed ID

9298325